Literature DB >> 23753232

Intraabdominal infections in the intensive care unit.

Ann-Kristin U Friedrich1, Mitchell Cahan2.   

Abstract

Intraabdominal infections are frequent and dangerous entity in intensive care units. Mortality and morbidity are high, causes are numerous, and treatment options are variable. The intensivist is challenged to recognize and treat intraabdominal infections in a timely fashion to prevent complications and death. Diagnosis of intraabdominal infection is often complicated by confounding underlying disease or masked by overall comorbidity. Current research describes a wide heterogeneity of patient populations, making it difficult to suggest a general treatment regimen and stressing the need of an individualized approach to decision making. Early focus-oriented intervention and antibiotic coverage tailored to the individual patient and hospital is warranted.
© The Author(s) 2013.

Entities:  

Keywords:  ICU; intraabdominal infection; peritonitis; source control

Mesh:

Substances:

Year:  2013        PMID: 23753232     DOI: 10.1177/0885066613476465

Source DB:  PubMed          Journal:  J Intensive Care Med        ISSN: 0885-0666            Impact factor:   3.510


  3 in total

1.  Clinical and Microbiological Characteristics of Patients with Complicated Intra-abdominal Infections in Intensive Care Unit.

Authors:  Yang-Mei Xiong; Xin Rao
Journal:  Curr Med Sci       Date:  2020-03-13

2.  Novel Multiparametric Nomogram for Overall Survival Prediction in Complicated Intra-Abdominal Infection: A Multicenter Study in China.

Authors:  Sisi Huang; Limin Chen; Jiao Liu; Sheng Zhang; Lidi Zhang; Zhenliang Wen; Yizhu Chen; Dechang Chen
Journal:  Front Med (Lausanne)       Date:  2021-02-22

3.  The Incidence, Clinical Outcomes, and Risk Factors of Thrombocytopenia in Intra-Abdominal Infection Patients: A Retrospective Cohort Study.

Authors:  Qin Wu; Jianan Ren; Gefei Wang; Guanwei Li; Guosheng Gu; Xiuwen Wu; Yuan Li; Jun Chen; Yunzhao Zhao; Jieshou Li
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.